Medicine and Dentistry
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
9%
Abdominal Wall
22%
Abdominal Wall Hernia
68%
Antithrombotic
9%
Arthroscopic Surgery
9%
Biological Marker
29%
Cancer Diagnosis
19%
Cancer Staging
12%
Carboplatin
9%
Case-Control Study
9%
Choledochotomy
9%
Cholelithiasis
9%
Chronic Pain
20%
Cine Magnetic Resonance Imaging
27%
Circulating Tumor DNA
48%
Cleft
9%
Clinical Trial
11%
Colon Carcinoma
9%
Colonoscopy
17%
Colorectal Cancer
59%
Colorectal Cancer Screening
32%
Colorectal Carcinoma
16%
Colorectal Tumor
9%
Combination Therapy
9%
Crohn's Disease
9%
Cross Sectional Study
29%
Diagnosis
10%
Digestive System Surgery
9%
DNA Mismatch Repair
9%
Echography
29%
Endometriosis
6%
Epigastric Hernia
9%
Fascia
12%
Femoral Hernia
9%
Femoroacetabular Impingement
9%
Foreign Body
9%
Fulminant Hepatic Failure
9%
Gastroesophageal Junction
9%
General Surgery
9%
Hazard Ratio
6%
Hernia
89%
Hernia Surgery
23%
Hernioplasty
80%
Herniotomy
12%
Hip
9%
Incision
9%
Incisional Hernia
33%
Ingestion
9%
Inguinal Hernia
55%
Intestine Necrosis
9%
Intestine Perforation
9%
Intubation
9%
Intussusception
9%
Knee Osteoarthritis
9%
Lactic Acid
9%
Laparoscopic Surgery
15%
Laparoscopy
11%
Malignant Neoplasm
20%
Meta-Analysis
9%
Metastatic Colorectal Cancer
19%
Negative Pressure Wound Therapy
9%
Neoplasm
23%
Neurinoma
9%
Next Generation Sequencing
9%
Noradrenalin
9%
Occult Blood Test
19%
Parastomal Hernia
19%
Patient Satisfaction
7%
Patient-Reported Outcome
10%
Pediatrics
9%
Pembrolizumab
19%
Pemetrexed
9%
Perforated Ulcer
9%
Peritonitis
8%
Pilonidal Cyst
9%
Postoperative Complication
13%
Postoperative Pain
25%
Primary Health Care
9%
Prolene
19%
Quality of Life
20%
Randomized Clinical Trial
29%
Randomized Controlled Trial
10%
Recurrence Risk
16%
Recurrent Disease
100%
Reoperation
26%
Retrospective Study
11%
Scanning Electron Microscopy
8%
Screening
13%
Second Cancer
9%
Sensitivity and Specificity
7%
Seroma
12%
Sinus Disease
9%
Surgeon
13%
Surgery
15%
Surgical Mesh
29%
Symptom
13%
Systematic Review
9%
Ventral Hernia Repair
60%
Vermiform Appendix
6%
Visual Analog Scale
14%
Pharmacology, Toxicology and Pharmaceutical Science
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
9%
Abdominal Wall Hernia
38%
Adenoma
6%
Anticoagulant Agent
9%
Autoimmune Hepatitis
9%
Biological Marker
16%
Cancer Staging
9%
Carboplatin
9%
Case-Control Study
9%
Chronic Pain
6%
Circulating Tumor DNA
9%
Cohort Study
9%
Colorectal Cancer
52%
Colorectal Carcinoma
11%
Combination Therapy
9%
Cross-Sectional Study
9%
Fulminant Hepatic Failure
9%
Hernia
34%
Inguinal Hernia
10%
Intestine Necrosis
9%
Malignant Neoplasm
20%
Metastatic Colorectal Cancer
19%
Minipig
9%
Noradrenalin
12%
Ovine Model
9%
Parastomal Hernia
19%
Pembrolizumab
9%
Pemetrexed
9%
Peritonitis
9%
Postoperative Complication
10%
Postoperative Pain
9%
Prostacyclin
6%
Recurrence Risk
6%
Recurrent Disease
67%
Scanning Electron Microscopy
14%
Second Cancer
10%
Seroma
9%
Xanthine Derivative
9%
Keyphrases
Accidental Ingestion
9%
Anchoring Device
9%
Autoimmune Hepatitis
9%
Bascom Cleft Lift
9%
Blood Biomarkers
9%
Closed Incision Negative Pressure Therapy
9%
Colorectal Cancer Screening
9%
Common Bile Duct Stones
9%
Early-onset Colorectal Cancer (EOCRC)
7%
Fatal Hepatitis
9%
Fecal Immunochemical Test
9%
Fulminant Hepatic Failure
9%
Grill Brush
9%
Healing
9%
Intestinal Necrosis
9%
Laparoscopic Common Bile Duct Exploration (LCBDE)
9%
Late-onset Colorectal Cancer
7%
Mesh Anchoring
9%
Mesh Properties
9%
Mesh Shrinkage
9%
Negative Pressure Wound Therapy
9%
Parastomal Hernia
9%
Parastomal Hernia Repair
9%
Pemetrexed
9%
Pilonidal Disease
9%
Population-based
10%
Registry-based
9%
Risk Factors
9%
Spontaneous Intestinal Perforation
9%
Transcystic
9%